It is well known that inflammation is a key component in colon cancer onset and progression and that the cyclooxygenase 2 (COX-2) pathways play a major role in modulating cell growth, apoptosis and epithelial mesenchymal transition (EMT) [27,28,29]. The gene discussed is PTGS2; the disease is colonic neoplasm.